Aurinia Pharmaceuticals Inc Revenue per Employee (AUPH), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Aurinia Pharmaceuticals Inc   (NASDAQ: AUPH)
 

Aurinia Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 18.87% in the second quarter 2026, year on year to cumulative value of $312 million, Aurinia Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,433,648, this marks a new company high.
Within the Healthcare sector Employees of 24 other companies have achieved higher revenue per employee. While Aurinia Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 257 to 372. Aurinia Pharmaceuticals Inc has 128 employees.


What is Sales per Employee Ratio?







AUPH Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 18.87 % 24.4 % 28.81 % 8.41 % 22.41 %
Sales per Employee (TTM) $ 2,433,648 2,330,430 2,211,367 2,076,625 2,032,117
AUPH's Total Ranking # 372 # 257 # 155 # 160 # 84
Seq. Revenue Change 7.1 % 0.77 % 4.96 % 4.94 % 12.08 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 17
Healthcare Sector # 25
Overall Market # 372

Revenue per Employee Statistics
High Average Low
$ 2,433,648 $ 1,311,946 $ 2,484
(Jun 30 2026)   (Dec 31 2019)



Financial Statements
Aurinia Pharmaceuticals Inc 's Revenue MRQ $ 83 Millions Visit AUPH's Income Statement
Aurinia Pharmaceuticals Inc 's Revenues TTM $ 312 Millions Visit AUPH's aggregate revenue growth
What are AUPH's Sales? Visit AUPH's Sales by Segment




Other Ratios
Aurinia Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
AUPH's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for AUPH's Competitors
Revenue per Employee for AUPH's Suppliers
Revenue per Employee for AUPH's Customers

You may also want to know
AUPH's Sales Growth Rates AUPH's Pe Price to earnings ratio AUPH's Receivables Turnover Ratio AUPH's Stock Quote
AUPH's Net Income Growth Rates AUPH's Ps Price to Sales ratio AUPH's Sales per Employee AUPH's Asset Turnover Ratio
AUPH's Net Margin AUPH's Pb Price to Book ratio AUPH's Financial Strength Ratios AUPH's Dividend Payout Ratio
Date modified: 2026-09-08T16:39:17+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Nuvation Bio Inc   3,943,046.51 $ 169.551  Million 43 
Halozyme Therapeutics Inc   3,933,186.76 $ 1,663.738  Million 423 
Ironwood Pharmaceuticals inc   3,893,160.00 $ 389.316  Million 100 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million
Amgen Inc   2,930,384.62 $ 38,095.000  Million 13,000 
Innoviva Inc   2,645,471.70 $ 420.630  Million 159 
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Sarepta Therapeutics Inc   2,364,483.83 $ 1,974.344  Million 835 
United Therapeutics Corporation  2,253,214.29 $ 3,154.500  Million 1,400 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Protagonist Therapeutics inc   2,136,303.03 $ 281.992  Million 132 
Exelixis Inc   2,123,731.47 $ 2,435.920  Million 1,147 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Alnylam Pharmaceuticals Inc   1,921,672.80 $ 4,804.182  Million 2,500 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.